A rapid, low-cost, cervical cancer screening platform
One of 5,497 projects Taiyo tracks in Belgium.
Source: EU Funding & Tenders Portal
Cervical cancer causes 13.000 deaths and 34.000 new cases in the European Union. 200M tests are performed worldwide per year representing a $3,4B market. Today two tests are performed to diagnose cervical cancer. Firstly, a cervical smear is analysed by a pathologist via a visual subjective inspection using traditional microscopy. This is an 8-step process performed by several persons at different
- Status
- Closed
- Location
- Belgium
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about A rapid, low-cost, cervical cancer screening platform
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | ended |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Cervical cancer causes 13.000 deaths and 34.000 new cases in the European Union. 200M tests are performed worldwide per year representing a $3,4B market. Today two tests are performed to diagnose cervical cancer. Firstly, a cervical smear is analysed by a pathologist via a visual subjective inspection using traditional microscopy. This is an 8-step process performed by several persons at different locations. Secondly, if positive, a molecular 4-step HPV test is performed. Results are available after 3 to 4 weeks causing anxiety and frustration for the patient. Typical instruments are expensive and have high related operational costs. Ovizio has designed a direct read vial allowing for the sample to be directly analysed without manipulation. The technology automatically generates objective data, identifying cells, detecting malicious cells and combines cytology and HPV in one test. This is a 3-step process: 1. sampling, 2. analysing, 3. report generation. The test is performed on a small low-cost device giving results in minutes rather than days allowing for near patient testing. A proof of concept and alpha prototype have been built with basic software algorithms. Several test have been performed at hospitals in Belgium and France resulting in two scientific publications and enthusiasm from key opinion leaders. The breakthrough technology transforms microscopic images into actionable data, corresponding to a market need of faster and improved testing, allowing healthcare organisations of member states to reduce costs and improve testing ratio’s. The company has a team that has done it before completed with highly skilled subject experts in the field and has launched 3 products laying the foundations for this project. |
Location
Country | Belgium |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Article published date | 2026-01-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More infrastructure projects in Belgium
- Norther Offshore Wind Farm
- ConAgra Foods Lamb Weston Frozen Potato Processing Facility Expansion
- Cargill’s Kalmthout Production Facility Expansion, Belgium
- UCB’s Gene Therapy Facility, Braine l’Alleud, Wallonia, Belgium
- USITOO4CITIES
- Modular Membrane Carbon Capture System
- ModuleOne
- Fuel generation & research facility
